SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY

被引:0
|
作者
Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Tipples, Graham
Sharifi, Nastaran
van Huyssteen, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bindra, Gurmeet
Mahoney, Douglas
Ingram, Richard
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph
Buie, Michael
Chan, Melissa
Ferraz, Jose
Lu, Cathy
Mathivanan, Meena
Novak, Kerri
Seow, Cynthia
Shukla, Tushar
Kaplan, Gilaad
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S48 / S48
页数:1
相关论文
共 50 条
  • [21] SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease
    Elkharsawi, Ahmed
    von Arnim, Ulrike
    Schmelz, Renate
    Sander, Cornelia
    Stallmach, Andreas
    Teich, Niels
    Walldorf, Jens
    Reuken, Philipp A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (01): : 77 - 80
  • [22] SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
    Selim, Rania
    Wellens, Judith
    Marlow, Luke
    Satsangi, Jack J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 989 - 989
  • [23] SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire
    Walldorf, Jens
    von Arnim, Ulrike
    Schmelz, Renate
    Riesner-Wehner, Anica
    Michl, Patrick
    Grunert, Philip C.
    Stallmach, Andreas
    Teich, Niels
    Reuken, Philipp A.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) : 1858 - 1861
  • [24] Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study
    Wasserbauer, Martin
    Hlava, Stepan
    Trojanek, Milan
    Stovicek, Jan
    Milota, Tomas
    Drabek, Jiri
    Koptova, Petra
    Cupkova, Andrea
    Pichlerova, Dita
    Kucerova, Barbora
    Coufal, Stepan
    Keil, Radan
    PLOS ONE, 2022, 17 (09):
  • [25] Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study
    Simon, David
    Tascilar, Koray
    Fagni, Filippo
    Kleyer, Arnd
    Kroenke, Gerhard
    Meder, Christine
    Dietrich, Peter
    Orlemann, Till
    Moessner, Johanna
    Taubmann, Jule
    Mutlu, Melek Yalcin
    Knitza, Johannes
    Kemenes, Stephan
    Liphardt, Anna-Maria
    Schoenau, Verena
    Bohr, Daniela
    Schuster, Louis
    Hartmann, Fabian
    Minopoulou, Ioanna
    Leppkes, Moritz
    Ramming, Andreas
    Pachowsky, Milena
    Schuch, Florian
    Ronneberger, Monika
    Kleinert, Stefan
    Hueber, Axel J.
    Manger, Karin
    Manger, Bernhard
    Atreya, Raja
    Berking, Carola
    Sticherling, Michael
    Neurath, Markus F.
    Schett, Georg
    LANCET RHEUMATOLOGY, 2022, 4 (09): : E614 - E625
  • [26] Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study
    Alhousseini, Ali
    Turkoglu, Onur
    Sajja, Sonia
    Wharton, Kurt
    Idler, Jay
    Bahado-Singh, Ray
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2022, 87 (3-4) : 219 - 225
  • [27] BIVALENT SARS-COV-2 VACCINATION YIELDS A STRONG SEROLOGICAL RESPONSE THAT IS COMPARABLE TO FOURTH DOSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Quan, Joshua
    Markovinovice, Ante
    Ma, Christopher
    Panaccione, Remo
    Hracs, Lindsay
    Sharifi, Nastaran
    Herauf, Michelle
    Coward, Stephanie
    Windsor, Joseph W.
    Caplan, Lea
    Ernest-Suarez, Kenneth
    Yeaman, Fiona
    Rowan, Catherine
    Ingram, Richard J.
    Holodinsky, Jessalyn K.
    Bernstein, Charles N.
    Mahoney, Douglas
    Bernatsky, Sasha
    Benchimol, Eric I.
    Kaplan, Gilaad
    GASTROENTEROLOGY, 2023, 164 (06) : S532 - S532
  • [28] SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study
    Karlowicz, Katarzyna
    Lewandowski, Konrad
    Tulewicz-Marti, Edyta
    Maciejewska, Katarzyna
    Tworek, Adam
    Stepien-Wrochna, Beata
    Gluszek-Osuch, Martyna
    Lodyga, Michal
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (02): : 198 - 205
  • [29] SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
    Garcia Mateo, S.
    Martinez-Dominguez, S. J.
    Aso Gonzalvo, M. C.
    Gargallo-Puyuelo, C. J.
    Gallego Llera, B.
    Arroyo Villarino, M. T.
    Laredo de la Torre, V.
    Nocito Colon, M. M. L.
    Lario Quilez, L.
    Refaie, E.
    Latre Santos, M.
    Gomollon Garcia, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S564 - S564
  • [30] PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION
    Li, Dalin
    Xu, Alexander
    Ebinger, Joseph
    Debbas, Philip
    Banty, Andrea
    Feldman, Edward J.
    Ha, Christina
    Lee, Susie
    Rabizadeh, Shervin
    Stein, Theodore
    Solomon, Theodore
    Syal, Gaurav
    Targan, Stephan R.
    Vasiliauskas, Eric A.
    Ziring, David
    Bonthala, Nirupama
    Hampton, Melissa
    Mujukian, Angela
    Pozdnyakova, Valeriya
    Gu, Phillip
    Joung, Sandy
    Appel, Keren
    Kumar, Rashmi
    Boland, Brigid S.
    Charabaty, Aline
    Chiorean, Michael V.
    Cohen, Erica
    Damas, Oriana M.
    Flynn, Ann D.
    Valentine, John F.
    Ehrlich, Adam C.
    Fudman, David
    Glover, Sarah C.
    Horizon, Arash A.
    Karayev, Dmitry
    Kretzmann, Benjamin
    Hou, Jason K.
    Hwang, Caroline
    Lazarev, Mark
    Lum, Donald
    Fausel, Rebecca
    Reddy, Swapna
    McConnell, Ryan
    Mattar, Mark
    Metwally, Mark
    Ostrov, Arthur
    Parekh, Nimisha K.
    Raffals, Laura H.
    Rubin, David T.
    Sheibani, Sarah
    GASTROENTEROLOGY, 2022, 162 (07) : S160 - S160